The chairman of the Division of Pediatric Hematology & Oncology and BMT at Cleveland Clinic Children's discussed results from the phase 1/2 RUBY trial he presented at ASH 2025.
Rabi Hanna, MD
Advertisement
The chairman of the Division of Pediatric Hematology & Oncology and BMT at Cleveland Clinic Children's.
Articles by Rabi Hanna, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
2
Deevyashali Parekh, MBBS, on Evaluating CAR-T in Patients With Multiple Myeloma and Renal Failure
3
Hematology-Oncology Immunotherapy Highlights at ASH 2025
4
Janna Minehart, MD, on Hematology-Oncology Immunotherapy Highlights at ASH 2025
5
